Government’s drug price caps may trigger showdown with US

US pharma biggies are at the receiving end of the Donald Trump administration’s ire due to rising drug prices in that country, and this may cause anxiety for the Indian government as well as domestic generic companies.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2Ou2fKt
via IFTTT